Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit
- PMID: 27659440
- PMCID: PMC5047998
- DOI: 10.3947/ic.2016.48.3.174
Clinical and Economic Evaluation of Multidrug-Resistant Acinetobacter baumannii Colonization in the Intensive Care Unit
Abstract
Background: The clinical and economic impact of multidrug-resistant (MDR) Acinetobacter baumannii colonization remains unclear. This study aimed to estimate and compare the mortality rates, length of stay (LOS), and hospitalization costs in the intensive care unit (ICU) for MDR A. baumannii colonized patients and a matched population.
Materials and methods: We performed a retrospective propensity score matched cohort study comparing the outcomes of patients with MDR A. baumannii colonization with those of uncolonized subjects matched at the time they were admitted to the ICU between January 2012 and December 2014.
Results: During the study period, 375 (7.5%) of the 4,779 patients were colonized with MDR A. baumannii. One hundred and twenty-two MDR A. baumannii colonized patients were compared with 122 uncolonized patients using propensity score matching. MDR A. baumannii colonized patients were likely to have a higher mortality rate compared to uncolonized patients (49.2% vs 32.0%; odds ratio [OR], 3.64). A longer ICU LOS and total admission days were observed in the MDR A. baumannii colonized patient group (4.14 and 4.67 days increase, OR 1.41 and 1.19). MDR A. baumannii colonization patients had an average extra ICU and total admission cost of $1,179 (₩1,261,334) and $1,333 (₩1,422,032) according to a multivariable regression model (OR, 1.27 and 1.17). Multivariable analysis identified the factors affecting ICU cost, which included, MDR A. baumannii colonization (OR = 1.33; P = 0.001), ICU LOS (OR = 1.97; P <0.001), valvular heart disease (OR = 1.12; P = 0.005), invasive devices (OR = 1.15; P = 0.018), and surgery (OR = 1.1; P < 0.001).
Conclusion: MDR A. baumannii colonization was associated with increased mortality, LOS, and costs in the ICU. A strict infection control program including preemptive isolation for high-risk groups would be helpful for reducing the burden of this infection.
Keywords: Acinetobacter baumannii; Infection control; Intensive care units.
Conflict of interest statement
No conflicts of interest.
Similar articles
-
Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.Am J Infect Control. 2014 Oct;42(10):1062-6. doi: 10.1016/j.ajic.2014.06.024. Am J Infect Control. 2014. PMID: 25278394
-
[The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Aug;27(8):667-71. doi: 10.3760/cma.j.issn.2095-4352.2015.08.010. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015. PMID: 26255016 Chinese.
-
[Risk factors and clinical outcomes for vancomycin-resistant enterococcus colonization on intensive care unit admission].J Korean Acad Nurs. 2013 Apr;43(2):287-95. doi: 10.4040/jkan.2013.43.2.287. J Korean Acad Nurs. 2013. PMID: 23703606 Korean.
-
A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii.Infect Control Hosp Epidemiol. 2018 May;39(5):525-533. doi: 10.1017/ice.2018.58. Epub 2018 Mar 27. Infect Control Hosp Epidemiol. 2018. PMID: 29580299
-
ICU-Acquired Colonization and Infection Related to Multidrug-Resistant Bacteria in COVID-19 Patients: A Narrative Review.Antibiotics (Basel). 2023 Sep 20;12(9):1464. doi: 10.3390/antibiotics12091464. Antibiotics (Basel). 2023. PMID: 37760760 Free PMC article. Review.
Cited by
-
Acinetobacter baumannii Isolates from COVID-19 Patients in a Hospital Intensive Care Unit: Molecular Typing and Risk Factors.Microorganisms. 2022 Mar 28;10(4):722. doi: 10.3390/microorganisms10040722. Microorganisms. 2022. PMID: 35456774 Free PMC article.
-
Effect of calcium on the interaction of Acinetobacter baumannii with human respiratory epithelial cells.BMC Microbiol. 2019 Nov 27;19(1):264. doi: 10.1186/s12866-019-1643-z. BMC Microbiol. 2019. PMID: 31771504 Free PMC article.
-
Risk factors for infection after carbapenem-resistant Acinetobacter baumannii colonization.Eur J Clin Microbiol Infect Dis. 2024 Nov;43(11):2191-2199. doi: 10.1007/s10096-024-04936-2. Epub 2024 Sep 16. Eur J Clin Microbiol Infect Dis. 2024. PMID: 39285106 Free PMC article.
-
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review.Antimicrob Resist Infect Control. 2019 Aug 13;8:137. doi: 10.1186/s13756-019-0590-7. eCollection 2019. Antimicrob Resist Infect Control. 2019. PMID: 31417673 Free PMC article.
-
Can flow cytometric measurements of reactive oxygen species levels determine minimal inhibitory concentrations and antibiotic susceptibility testing for Acinetobacter baumannii?PLoS One. 2024 Jun 24;19(6):e0305939. doi: 10.1371/journal.pone.0305939. eCollection 2024. PLoS One. 2024. PMID: 38913680 Free PMC article.
References
-
- Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis. 1987;9:1065–1078. - PubMed
-
- Montefour K, Frieden J, Hurst S, Helmich C, Headley D, Martin M, Boyle DA. Acinetobacter baumannii: an emerging multidrug-resistant pathogen in critical care. Crit Care Nurse. 2008;28:15–25. - PubMed
-
- Young LS, Sabel AL, Price CS. Epidemiologic, clinical, and economic evaluation of an outbreak of clonal multidrug-resistant Acinetobacter baumannii infection in a surgical intensive care unit. Infect Control Hosp Epidemiol. 2007;28:1247–1254. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources